Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies

Overview of attention for article published in JAMA Network Open, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 8 news outlets
twitter: 34 X users

facebook: 1 Facebook page

Readers on

mendeley: 150 Mendeley

So far, Altmetric has seen 9 news stories from 8 outlets.

CBD Gel Effective for Seizure Reduction in Children With Encephalopathies

Neurology Advisor , 13 Oct 2021

Cannabidiol (CBD) transdermal gel reduced focal impaired awareness seizures (FIAS) and tonic-clonic seizures (TCS) frequency…

CBD Gel a Promising Adjunct for Kids With Severe Epilepsy

Medscape, 16 Sep 2021

Topical cannabidiol (CBD) gel, added to antiseizure medication, may help reduce seizures and improve quality of life in…

CBD gel reduces seizures in children with encephalopathies

Healio.com, 13 Sep 2021

September 13, 2021 2 min read Source/Disclosures Disclosures: Scheffer reports numerous relevant financial disclosures.

Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Network Open

FirstWord Pharma, 07 Sep 2021

DEVON, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 5 additional news stories.